Single-Sample Germline Variant Filtering for Accurate TMB

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for variant calling from sequence data struggle to accurately distinguish somatic variants from germline variants without requiring matched normal samples, leading to potential overestimation of tumor mutation burden.

Innovation Solution

A method involving a database filter and a proximity filter is applied to sequence data from a single sample to identify and remove germline variants based on allele count and genomic location, allowing for the distinction between somatic and germline variants.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If traditional variant calling methods are used without matched normal samples, then the process is simpler and costs are reduced, but the accuracy of distinguishing somatic variants from germline variants deteriorates

Engineering Contradiction:
Improveease of sample preparationVSAvoidaccuracy of variant classification
Core Design Contradiction:
Ease of manufactureVSMeasurement precision

Solution Approach 1:

The patent introduces population frequency data from reference databases as an intermediary to distinguish germline variants. By comparing the variant allele frequency in the tumor sample against the frequency observed in normal population databases, the method can identify germline variants (which appear in both tumor and population databases) without requiring matched normal samples. This intermediary reference data enables accurate variant classification while maintaining the simplified single-sample approach.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If traditional variant calling methods are used without matched normal samples, then the workflow is faster and more efficient, but the reliability of tumor mutation burden estimation deteriorates

Engineering Contradiction:
Improveworkflow efficiencyVSAvoidreliability of tumor mutation burden estimation
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent implements a feedback mechanism by iteratively comparing variant allele frequencies against population database frequencies. The method calculates the ratio of tumor variant frequency to population variant frequency, and uses this feedback to classify variants as somatic or germline. This feedback loop enables reliable tumor mutation burden estimation while maintaining workflow efficiency, as it eliminates the need for additional matched normal sample processing steps.

Inventive Principle:
Principle #23Feedback

3Measurement precision

If database filtering is applied to remove germline variants, then somatic variant identification becomes more accurate, but the complexity of the variant calling process increases

Engineering Contradiction:
Improveaccuracy of somatic variant identificationVSAvoidcomplexity of bioinformatics pipeline
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent simplifies the filtering process by changing the approach from complex multi-step filtering to a straightforward frequency ratio comparison. Instead of applying multiple filtering criteria, the method transforms the problem into comparing a single key parameter: the ratio of tumor variant allele frequency to population variant allele frequency. This parameter transformation maintains high accuracy in somatic variant identification while significantly reducing bioinformatics pipeline complexity.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS20260051365A1Methods and compositions for germline variant detection
Publication Date: 2026.02.19 ILLUMINA INC
  • US20260051365A1 patent drawing
  • US20260051365A1 patent drawing
  • US20260051365A1 patent drawing

AI summary

Some embodiments of the methods and systems provided herein relate to variant calling from sequence data obtained from a single sample. In some embodiments, a somatic variant can be distinguished from a germline variant based on variant allele frequency in a sample and location in a genome.